Synbio Tech Inc(TW:1295)
NT$41.90+0.10 (+0.24%)
TW:1295
Synbio Tech Inc financials statements
NT$41.90
At close:+0.10 (+0.24%)
Synbio Tech Inc (1295) Ratios
Synbio Tech Inc Ratios
TW:1295's free cash flow for Q2 2026 was NT$49.86M. For the 2026 fiscal year, TW:1295's free cash flow was decreased by NT$-21.63M and operating cash flow was NT$71.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.20 | 1.86 | 3.10 | 2.99 | 1.90 |
| Quick Ratio | 0.83 | 1.46 | 2.36 | 2.29 | 1.46 |
| Cash Ratio | 0.59 | 1.14 | 1.74 | 1.02 | 0.52 |
| Solvency Ratio | 0.15 | 0.19 | 0.20 | 0.22 | 0.35 |
| Operating Cash Flow Ratio | 0.22 | 0.64 | 1.07 | 0.84 | 0.74 |
| Short-Term Operating Cash Flow Coverage | 0.42 | 1.62 | 7.76 | 2.19 | 1.41 |
| Net Current Asset Value | NT$ -945.97M | NT$ -499.35M | NT$ -324.63M | NT$ -112.81M | NT$ 1.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.41 | 0.39 | 0.38 | 0.33 |
| Debt-to-Equity Ratio | 1.04 | 0.88 | 0.78 | 0.70 | 0.59 |
| Debt-to-Capital Ratio | 0.51 | 0.47 | 0.44 | 0.41 | 0.37 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.38 | 0.38 | 0.31 | 0.18 |
| Financial Leverage Ratio | 2.32 | 2.17 | 2.00 | 1.87 | 1.78 |
| Debt Service Coverage Ratio | 0.72 | 1.51 | 5.76 | 1.91 | 1.24 |
| Interest Coverage Ratio | 15.61 | 56.43 | 21.68 | 13.24 | 23.80 |
| Debt to Market Cap | 0.44 | 0.35 | 0.23 | 0.21 | 0.16 |
| Interest Debt Per Share | 42.07 | 30.54 | 23.53 | 20.38 | 16.69 |
| Net Debt to EBITDA | 3.64 | 1.53 | 1.67 | 2.01 | 1.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.45% | 54.66% | 50.86% | 48.87% | 52.14% |
| EBIT Margin | 19.48% | 24.29% | 18.66% | 16.69% | 22.90% |
| EBITDA Margin | 26.72% | 31.97% | 28.00% | 27.14% | 31.31% |
| Operating Profit Margin | 19.09% | 21.16% | 17.36% | 13.77% | 21.80% |
| Pretax Profit Margin | 19.48% | 23.91% | 17.86% | 15.65% | 21.99% |
| Net Profit Margin | 16.94% | 17.19% | 13.76% | 12.51% | 18.69% |
| Continuous Operations Profit Margin | 16.94% | 17.19% | 13.76% | 12.51% | 18.69% |
| Net Income Per EBT | 86.96% | 71.91% | 77.02% | 79.97% | 85.02% |
| EBT Per EBIT | 102.07% | 112.99% | 102.87% | 113.62% | 100.87% |
| Return on Assets (ROA) | 5.70% | 7.26% | 6.01% | 5.52% | 10.43% |
| Return on Equity (ROE) | 13.23% | 15.76% | 12.01% | 10.31% | 18.53% |
| Return on Capital Employed (ROCE) | 8.11% | 10.83% | 8.47% | 7.00% | 15.81% |
| Return on Invested Capital (ROIC) | 6.19% | 7.18% | 6.41% | 5.28% | 11.58% |
| Return on Tangible Assets | 5.74% | 7.33% | 6.07% | 5.60% | 10.57% |
| Earnings Yield | 6.22% | 7.23% | 4.44% | 3.87% | 6.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.66 | 8.77 | 75.05 | 74.91 | 63.90 |
| Payables Turnover | 18.47 | 12.45 | 13.41 | 16.67 | 12.58 |
| Inventory Turnover | 2.04 | 2.74 | 2.73 | 2.42 | 2.64 |
| Fixed Asset Turnover | 0.46 | 0.65 | 0.67 | 0.77 | 1.06 |
| Asset Turnover | 0.34 | 0.42 | 0.44 | 0.44 | 0.56 |
| Working Capital Turnover Ratio | 4.28 | 2.56 | 1.91 | 1.94 | 3.49 |
| Cash Conversion Cycle | 207.19 | 145.33 | 111.11 | 133.52 | 115.04 |
| Days of Sales Outstanding | 47.67 | 41.64 | 4.86 | 4.87 | 5.71 |
| Days of Inventory Outstanding | 179.28 | 133.01 | 133.47 | 150.53 | 138.35 |
| Days of Payables Outstanding | 19.76 | 29.32 | 27.22 | 21.89 | 29.02 |
| Operating Cycle | 226.95 | 174.65 | 138.33 | 155.41 | 144.06 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.31 | 8.34 | 6.82 | 5.99 | 8.53 |
| Free Cash Flow Per Share | -16.83 | -1.58 | -3.63 | -1.06 | 7.08 |
| Dividend Paid and CapEx Coverage Ratio | 0.18 | 0.73 | 0.55 | 0.64 | 2.50 |
| Capital Expenditure Coverage Ratio | 0.20 | 0.84 | 0.65 | 0.85 | 5.89 |
| Operating Cash Flow Coverage Ratio | 0.10 | 0.27 | 0.29 | 0.30 | 0.52 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.26 | 0.26 | 0.25 | 0.31 |
| Free Cash Flow Yield | -19.80% | -2.10% | -4.46% | -1.39% | 9.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.07 | 13.79 | 22.54 | 25.83 | 14.71 |
| Price-to-Sales (P/S) Ratio | 2.72 | 2.38 | 3.10 | 3.23 | 2.75 |
| Price-to-Book (P/B) Ratio | 2.13 | 2.18 | 2.71 | 2.66 | 2.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.05 | -47.59 | -22.44 | -71.98 | 10.80 |
| Price-to-Operating Cash Flow Ratio | 19.72 | 8.99 | 11.93 | 12.77 | 8.96 |
| Price-to-Earnings Growth (PEG) Ratio | -5.83 | 0.27 | 1.03 | -0.60 | 0.62 |
| Enterprise Value Multiple | 13.83 | 8.97 | 12.74 | 13.91 | 9.99 |
| Enterprise Value | 3.84B | 2.84B | 2.94B | 2.79B | 2.68B |
| EV to EBITDA | 13.83 | 8.97 | 12.74 | 13.91 | 9.99 |
| EV to Sales | 3.69 | 2.87 | 3.57 | 3.77 | 3.13 |
| EV to Free Cash Flow | -6.86 | -57.39 | -25.83 | -84.11 | 12.27 |
| EV to Operating Cash Flow | 26.77 | 10.84 | 13.73 | 14.92 | 10.19 |
| Tangible Book Value Per Share | 40.53 | 33.67 | 29.70 | 28.43 | 27.58 |
| Shareholders’ Equity Per Share | 39.99 | 34.43 | 30.05 | 28.74 | 28.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.28 | 0.23 | 0.20 | 0.15 |
| Revenue Per Share | 31.22 | 31.56 | 26.24 | 23.67 | 27.77 |
| Net Income Per Share | 5.29 | 5.43 | 3.61 | 2.96 | 5.19 |
| Tax Burden | 0.87 | 0.72 | 0.77 | 0.80 | 0.85 |
| Interest Burden | 1.00 | 0.98 | 0.96 | 0.94 | 0.96 |
| Research & Development to Revenue | 0.11 | 0.11 | 0.10 | 0.11 | 0.10 |
| SG&A to Revenue | 0.21 | 0.23 | 0.23 | 0.24 | 0.20 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.81 | 1.11 | 1.45 | 1.62 | 1.40 |
Currency in TWD
